Senior Software Engineer

Hyderabad, Telangana, India

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess 8+ years of experience in full-stack development and automation, ideally with a focus on business process management solutions, proficiency in at least one programming language (Python, Java, etc.) with Linux/UNIX OS and UI Technologies (React JS), experience working with BPM tools such as Camunda 7, 8 and Bonitasoft, Database experience in SQL, PL/SQL Prog, Mongo DB, experience using version control systems (GitHub etc.,) and Documentation (Technical), experience developing, deploying and maintenance of applications in Amazon Web Services (AWS) cloud, and experience in Designing the spring cloud application with the latest spring boot version. Custom application development using Node/React/Angular, workflow orchestration & task automation, and experience in developing API integration and web services are also required. Familiarity with agile development methodologies is beneficial.

Responsibilities

The Senior Software Engineer will design and develop process automation solutions utilizing BMS Camunda 8 platform, Amazon Web Services (AWS), and bespoke application development in Java/Python, work with stakeholders to understand requirements and design solutions, integrate solutions with other systems, troubleshoot and resolve issues, collaborate with cross-functional teams to identify process improvements, develop and maintain documentation, stay up-to-date with emerging technologies, and mentor other team members effectively.

Skills

Business Process Management (BPM)

Camunda 7

Camunda 8

Bonita soft

Amazon Web Services (AWS)

Java

Software Development

Application Development

Teamwork

Collaboration

Communication

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free